Priority-driven collaborative cancer research – young investigator project grants (Cancer Australia)

Cancer Australia, in collaboration with its funding partners, invites applications for its priority-driven collaborative cancer research young investigator project grants. These support research in identified priority areas to help reduce the impact of cancer in the community and improve outcomes for people affected by cancer. 

There are two categories of grants:

•category B – involves partnerships between Cancer Australia and Cure Cancer Australia, and comprises grants awarded for one year duration with maximum funding of $100,000 to support researchers with one to three years post-doctoral experience, or one to three years after graduation from medical school;

•category C – involves partnerships between Cancer Australia and Cure Cancer Australia, and comprises grants awarded for two years duration with maximum funding of $200,000, with maximum funding per year of $100,000, to support post-doctoral researchers with four to seven years post-doctoral experience, or four to seven years after graduation from medical school.

The proposed research must directly align with at least one research priority area specified by Cancer Australia or its funding partners. Applicants must be qualified researchers who will be conducting research at an NHMRC approved administering institution in Australia. Chief investigators or co-investigators on current NHRMC programme or project grants who form research collaborations are also eligible. The administering institution can be within a university, affiliated to a university or major hospital, or an appropriate independent medical or scientific research institute and must meet NHMRC requirements.

• Closing date 27 Jan 2016   More information here.